triazoles has been researched along with Depressive Disorder in 158 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.27) | 18.7374 |
| 1990's | 90 (56.96) | 18.2507 |
| 2000's | 61 (38.61) | 29.6817 |
| 2010's | 4 (2.53) | 24.3611 |
| 2020's | 1 (0.63) | 2.80 |
| Authors | Studies |
|---|---|
| Cully, M | 1 |
| Chang, CH; Chen, SJ; Liu, CY | 1 |
| Bertorelli, R; Cohen-Williams, ME; Forlani, A; Foster, C; Fredduzzi, S; Higgins, GA; Hodgson, RA; Hunter, JC; Impagnatiello, F; Lachowicz, JE; Neustadt, BR; Nicolussi, E; Parker, EM; Parra, LE; Reggiani, A; Stamford, AW; Varty, GB; Zhai, Y | 1 |
| Argyropoulos, SV; Bell, CJ; Hicks, JA; Nash, JR; Nutt, DJ; Rich, AS; Wilson, S | 1 |
| Aubry, JM; Bertschy, G; Bondolfi, G; Gex-Fabry, M; Kosel, M; Malafosse, A; Perroud, N; Uher, R | 1 |
| Furukawa, S; Kumagi, T; Matsuura, B; Miyake, T; Murakami, M; Murakami, S; Niiya, T; Nishino, K; Onji, M; Ueda, T | 1 |
| Arnow, BA; Constantino, MJ; Klein, DN; Laws, HB; Manber, R; Rothbaum, BO | 1 |
| Arias, F; Carrasco, JL; Díaz-Marsá, M; Huertas, D; Ibañez, A; Martín-Carrasco, M; Moreno, I; Rico-Villademoros, F; Saiz-Ruiz, J | 1 |
| Arnow, BA; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kornstein, SG; Manber, R; Ninan, PT; Rush, AJ; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
| Samuels, S; Thompson, M | 1 |
| Ehrentraut, S; Gerbes, AL; Kapfhammer, HP; Rau, HG; Rothenhäusler, HB; Schirren, CA; Thiel, M | 1 |
| Bobkiewicz-Kozłowska, T; Kus, K; Nowakowska, E | 1 |
| Born, C; Grunze, H; Marcuse, A; Schärer, LO; Walden, J | 1 |
| Hackett, LP; Isbister, GK | 1 |
| Bobadilla, L; Brown, ES; Dhillon, H; Frol, A; Nejtek, VA; Perantie, D | 1 |
| Bagby, RM; Grigoriadis, S; Kennedy, SH | 1 |
| Croft, HA; Labbate, LA; Oleshansky, MA | 1 |
| HOZUMI, M; SUGIMURA, T | 1 |
| Monaghan, MS; Skrabal, MZ; Stading, JA | 1 |
| Dremencov, E; Gispan-Herman, I; Mendelman, A; Overstreet, DH; Rosenstein, M; Yadid, G; Zohar, J | 1 |
| Chen, S; Hundal, KS; Joshi, N; Moore, W; Tranos, P | 1 |
| Goulart, EC; Kaster, MP; Rodrigues, AL; Rosa, AO; Rosso, MM; Santos, AR | 1 |
| Baram, VY; Conway, CR; McGuire, JM | 1 |
| Albert, PR; Bakish, D; Du, L; Hrdina, P; Lemonde, S | 1 |
| Arnow, B; Borian, FE; Carmody, TJ; Dunner, DL; Fawcett, J; Gelenberg, AJ; Ibrahim, HM; Jody, DN; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Nemeroff, CB; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH | 1 |
| Ciraulo, AM; Ciraulo, DA; Greenblatt, DJ; Knapp, C; Leiderman, D; LoCastro, J; Rotrosen, J; Sarid-Segal, O | 1 |
| Ammar, H; Malani, AK | 1 |
| Dubarek, W; Kucia, K | 1 |
| Goldberg, RJ | 2 |
| Kupecz, D | 1 |
| Sussman, N | 1 |
| Nelson, EC | 1 |
| Preskorn, SH | 1 |
| Carter, RB; Eison, AS; Mullins, UL; Smith, HL; Taylor, DP; Torrente, JR; Wright, RN; Yocca, FD | 1 |
| Anton, SF; Francis, RJ; Marcus, RN; Mendels, J; Reimherr, F; Roberts, DL | 1 |
| Anton, SF; Fawcett, J; Marcus, RN; O'Brien, K; Schwiderski, U | 1 |
| Marcus, RN; Rickels, K; Roberts, DL; Robinson, DS; Schweizer, E | 1 |
| Nemeroff, CB | 1 |
| Anton, SF; Archibald, DG; English, PA; Kensler, TT; Roberts, DL; Robinson, DS | 1 |
| Ansseau, M; Darimont, P; De Nayer, A; Devoitille, JM; Dierick, M; Evrard, JL; Krémer, P; Lecoq, A; Mertens, C; Mesotten, F | 1 |
| Clary, C; Fox, I; Rickels, K; Schweizer, E; Weise, C | 1 |
| Armitage, R; Cain, J; Roffwarg, HP; Rush, AJ; Trivedi, M | 1 |
| Ecker, JA; Elie, R; Faludi, G; Fontaine, R; Kaplita, S; Kensler, TT; Ontiveros, A; Roberts, DL | 1 |
| Cloninger, CR; Nelson, EC | 1 |
| Debattista, C; Sofuoglu, M | 1 |
| Zajecka, JM | 1 |
| Cohn, CK; Ieni, JR; O'Brien, K; Roberts, DL; Robinson, DS; Schwiderski, UE | 1 |
| Marcus, RN; Mendels, J | 1 |
| Montgomery, SA | 1 |
| Kaplita, SB; Marcus, RN; Roberts, DL; Robinson, DS; Seminara, JA; Smith, JM; Stringfellow, JC | 1 |
| Lader, MH | 1 |
| Abed, RT; Ascher, A; Baldwin, DS; Buckingham, SA; Cox, J; Hawley, CJ; Maragakis, BP; Pover, GH | 1 |
| Archibald, DG; Hardy, SA; Marcus, RN; Robinson, DS | 1 |
| Rothschild, AJ | 1 |
| DeMartinis, NA; Rickels, K; Schweizer, E | 1 |
| Callahan, AM; Ketter, TA; Post, R | 1 |
| Shammi, C | 1 |
| Ghaemi, SN; Irizarry, MC | 1 |
| Ellingrod, VL; Perry, PJ | 1 |
| Brown, RE; Clark, M; Montgomery, SA | 1 |
| Kraus, RP | 1 |
| Stoudemire, A | 1 |
| Adler, LA; Angrist, B; Eberstein, S | 1 |
| Simpson, JS | 1 |
| Micheal, A; Ramana, R | 1 |
| Langer, SF; Pecknold, JC | 1 |
| Blaisdell, GD; Jermain, DM; Zaphiris, HA | 1 |
| Gilroy, WR; Gupta, S | 1 |
| Biggs, F; Warnock, JK | 1 |
| Clark, A; Livingston, MG | 1 |
| Brown, RE; Culpepper, L; Gonzales, J; Hales, RE; Keller, MB; Revicki, DA | 1 |
| Reynolds, RD | 1 |
| Dubin, H; Giannandrea, P; Spier, S | 1 |
| Bryson, HM; Davis, R; Whittington, R | 1 |
| Möller, HJ; Volz, HP | 1 |
| Yonkers, KA | 1 |
| Armitage, R; Cole, D; Rush, AJ; Yonkers, K | 1 |
| Albala, BJ; Erman, MK; Gillin, JC; Rapaport, M; Winokur, A | 1 |
| Benazzi, F | 2 |
| Schwartz, K | 1 |
| van Laar, MW | 1 |
| Bakish, D; Hooper, CL; Miller, CA; Thibaudeau, CA; Thornton, MD; Wiens, A | 1 |
| Frazer, A | 1 |
| Nelson, JC | 1 |
| Cloninger, CR; Nelson, E | 1 |
| Barbhaiya, RH; Greene, DS | 1 |
| Anderson, G; Cellar, J; Mallison, RT; Narayan, M; Nelson, JC; Price, LH | 1 |
| Case, WG; DeMartinis, N; Garcia España, FG; Greenblatt, DJ; Mandos, LA; Rickels, K; Schweizer, E | 1 |
| Nemeroff, CB; Owen, JR | 1 |
| Bennett, ME; D'Amico, MF; Feighner, J; Hardy, SA; Kensler, TT; Roberts, DL; Targum, SD | 1 |
| Albala, BJ; Armitage, R; Erman, MK; Fleming, JB; Gillin, JC; Kaplita, SB; McQuade, RD; Moldofsky, H; Montplaisir, J; Rush, AJ; Vogel, GW; Winokur, A; Yonkers, KA | 1 |
| Richelson, E | 1 |
| Beckham, JC; Davidson, JR; Feldman, ME; Hertzberg, MA; Moore, SD | 1 |
| Hamilton, SP; Klimchak, C; Nunes, EV | 1 |
| Campo, JV; Perel, JM; Smith, C | 1 |
| Stahl, SM | 1 |
| Balon, R | 1 |
| Anton, SF; Bakish, D; Brown, RE; Feeny, D; Palmer, W; Revicki, DA; Rosser, WW | 1 |
| Bergam, K; Claypoole, K; Elliott, AJ; Roy-Byrne, PP; Russo, J; Uldall, KK | 1 |
| Archibald, DG; Bielski, RJ; Bremner, J; Feiger, AD; Heiser, JF; Kaplita, SB; Kensler, TT; McQuade, RD; Roberts, DL; Trivedi, M; Wilcox, CS | 1 |
| Horst, WD; Preskorn, SH | 1 |
| Thase, ME | 1 |
| Hirschfeld, RM | 1 |
| Appelberg, B; Joffe, G; Rimón, R | 1 |
| Brodie-Meijer, CC; Buijs, PJ; Diemont, WL | 1 |
| Little, J; Rajagopalan, M | 1 |
| DeVane, CL; Pollock, BG | 1 |
| Fava, M | 1 |
| Kent, JM | 1 |
| Benzick, JM; Faber, RA | 1 |
| Arnow, B; Dunner, DL; Gelenberg, AJ; Keller, MB; Klein, DN; Markowitz, JC; McCullough, JP; Nemeroff, CB; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
| Scott, J | 1 |
| Lerner, V; Matar, MA; Polyakova, I | 1 |
| Dunn, NR; Mackay, FJ; Mann, RD | 1 |
| Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
| Goodnick, PJ; Hunter, T; Jorge, CA; Kumar, AM | 1 |
| Kocsis, JH | 1 |
| D'Amico, F; Findling, RL; Magnus, RD; Marathe, P; Marcus, RN; Preskorn, SH; Reed, MD | 1 |
| Baty, P | 1 |
| Khouzam, HR | 1 |
| Rubin, RT | 1 |
| Umanoff, DF | 1 |
| Duncan, BL; Miller, SD | 1 |
| Veijola, JM | 1 |
| Izquierdo, JA; Llorca, G; Montejo, AL; Rico-Villademoros, F | 1 |
| Ferguson, JM | 1 |
| Baker, SM; Trivedi, MH | 1 |
| Borian, F; Ferguson, JM; Hartford, JT; Ieni, J; Jody, D; McQuade, RD; Shrivastava, RK; Stahl, SM | 1 |
| Carmody, TJ; Pan, JY; Rush, AJ; Trivedi, MH | 1 |
| Dunner, DL | 1 |
| Bikoff, J; Ginsberg, DL; Sussman, N | 1 |
| Volz, HP | 1 |
| Devarajan, S; Dursun, SM; Kutcher, S | 1 |
| Baruch, Y; Chelben, J; Lustig, M; Strous, RD | 1 |
| Bertschy, G; Roth, L | 1 |
| Keller, MB | 1 |
| Alderman, CP; Condon, JT; Gebauer, MG; Gilbert, AL | 1 |
| Carvajal García-Pando, A; García del Pozo, J; Lucena, MI; Rueda de Castro, AM; Sánchez, AS; Velasco, MA | 1 |
| DeVane, CL; Grothe, DR; Smith, SL | 1 |
| Keller, MB; Laird, LK; Prather, MR; Rush, AJ; Schatzberg, AF; Wright, CW | 1 |
| Brady, KT; Charney, DS; Grothe, DR; Kaltsounis-Puckett, J; Laird, LK; Rush, AJ; Smith, SL; Wright, CW | 1 |
| Bailey, L; Dunner, DL; Laird, LK; Seabolt, JL; Sussman, N; Zajecka, J | 1 |
| Lusk, KM; McEnany, GW; Zajecka, J | 1 |
| Brunson, GH; Hales, RE; Hilty, DM | 1 |
| Borian, FE; Crits-Christoph, P; Keller, MB; Kornstein, SG; Manber, R; Ninan, PT; Rothbaum, BO; Rush, AJ; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
| Argyropoulos, SV; Bell, CJ; Edwards, C; Hicks, JA; Nash, JR; Nutt, DJ; Rich, AS; Wilson, SJ | 1 |
| Borian, FE; Dunner, DL; Friedman, ES; Keller, MB; Klein, DN; Kornstein, SG; Manber, R; Markowitz, JC; Ninan, PT; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH | 1 |
| Fontaine, R | 1 |
| Copp, JE; Robinson, DS; Schwiderski, UE | 1 |
| Copp, J; D'Amico, MF; Roberts, DL; Robinson, DS; Schwiderski, UE | 1 |
| Boyer, WF; D'Amico, MF; Feighner, JP; Fowler, RC; Pambakian, R | 1 |
43 review(s) available for triazoles and Depressive Disorder
| Article | Year |
|---|---|
Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and a review of the literature.
Topics: Aged, 80 and over; Biguanides; Blood Glucose; Depressive Disorder; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Overdose; Female; Glucose; Humans; Hypoglycemic Agents; Pyrazines; Sitagliptin Phosphate; Suicide, Attempted; Sulfonylurea Compounds; Triazoles | 2012 |
[Pharmacological justification for the use of new antidepressant drugs].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Triazoles; Venlafaxine Hydrochloride | 2002 |
Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.
Topics: Antidepressive Agents; Bupropion; Controlled Clinical Trials as Topic; Depressive Disorder; Doxepin; Drug Tolerance; Erectile Dysfunction; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Orgasm; Piperazines; Remission, Spontaneous; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triazoles | 2003 |
[Applications and safety of modern antidepressants in patients with liver diseases].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 2007 |
Nefazodone and venlafaxine: two new agents for the treatment of depression.
Topics: Antidepressive Agents; Consumer Product Safety; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Family Practice; Humans; Norepinephrine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1995 |
New antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Fluvoxamine; Humans; Piperazines; Triazoles | 1995 |
The potential benefits of serotonin receptor-specific agents.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Humans; Isoxazoles; Ondansetron; Piperazines; Piperidines; Receptors, Serotonin; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Sumatriptan; Triazoles | 1994 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Nociceptors; Piperazines; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Serotonin; Triazoles | 1995 |
Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Piperazines; Placebos; Psychomotor Agitation; Randomized Controlled Trials as Topic; Triazoles | 1995 |
Evolutionary trends in the pharmacotherapeutic management of depression.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Child; Clinical Trials as Topic; Cyclohexanols; Decision Trees; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Piperazines; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 1994 |
Efficacy in long-term treatment of depression.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Imipramine; Long-Term Care; Piperazines; Placebos; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Treatment Outcome; Triazoles | 1996 |
The safety profile of nefazodone.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Mixed Function Oxygenases; Piperazines; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles; Weight Gain | 1996 |
Tolerability and safety: essentials in antidepressant pharmacotherapy.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depressive Disorder; Dizziness; Drug Overdose; Humans; Incidence; Nausea; Patient Dropouts; Piperazines; Placebos; Sleep; Treatment Outcome; Triazoles; Xerostomia | 1996 |
The diagnosis and treatment of late-life depression.
Topics: Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 1996 |
Nefazodone: a new antidepressant.
Topics: Animals; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Piperazines; Triazoles | 1995 |
New antidepressant drugs and the treatment of depression in the medically ill patient.
Topics: Adjustment Disorders; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Patient Care Team; Piperazines; Selective Serotonin Reuptake Inhibitors; Sick Role; Triazoles; Venlafaxine Hydrochloride | 1996 |
Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Piperazines; Triazoles | 1997 |
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1996 |
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Mental Disorders; Panic Disorder; Piperazines; Premenstrual Syndrome; Psychotherapy; Risk Factors; Sertraline; Sodium Lactate; Triazoles | 1997 |
Antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1997 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride | 1997 |
Clinical pharmacokinetics of nefazodone.
Topics: Adult; Age Factors; Aged; Analgesics; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Female; Humans; Kidney Diseases; Liver Diseases; Male; Piperazines; Sex Factors; Triazoles | 1997 |
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Humans; Isoenzymes; Mianserin; Mirtazapine; Piperazines; Risk Factors; Triazoles; Venlafaxine Hydrochloride | 1998 |
Pharmacokinetic interactions of antidepressants.
Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1998 |
Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Depressive Disorder; Drug Prescriptions; Humans; Monoamine Oxidase Inhibitors; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1998 |
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Piperazines; Triazoles; Venlafaxine Hydrochloride | 1998 |
Antidepressant treatment of the depressed patient with insomnia.
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1999 |
Care of the sexually active depressed patient.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Sexual Dysfunctions, Psychological; Triazoles | 1999 |
Pharmacokinetic considerations of antidepressant use in the elderly.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Biotransformation; Bupropion; Creatinine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Half-Life; Humans; Intestinal Absorption; Liver; Male; Middle Aged; Piperazines; Triazoles; Venlafaxine Hydrochloride | 1999 |
New approaches to the treatment of refractory depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Pindolol; Piperazines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Triazoles; Triiodothyronine | 2000 |
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Morpholines; Piperazines; Reboxetine; Structure-Activity Relationship; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2000 |
New strategies for treating chronic depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Treatment Outcome; Triazoles | 2000 |
The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration.
Topics: Antidepressive Agents, Second-Generation; Biological Availability; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Piperazines; Somatoform Disorders; Treatment Outcome; Triazoles | 2000 |
The effects of antidepressants on sexual functioning in depressed patients: a review.
Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Single-Blind Method; Triazoles | 2001 |
Clinical significance of monitoring early symptom change to predict outcome.
Topics: Algorithms; Citalopram; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Piperazines; Probability; Prognosis; Recurrence; Remission Induction; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Triazoles | 2001 |
Acute and maintenance treatment of chronic depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Dysthymic Disorder; Humans; Multicenter Studies as Topic; Piperazines; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Triazoles | 2001 |
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Controlled Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Triazoles; Weight Gain | 2001 |
Pharmacology of antidepressants: focus on nefazodone.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Drug Interactions; Humans; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Triazoles | 2002 |
Clinical use of nefazodone in major depression: a 6-year perspective.
Topics: Age Factors; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Hospitalization; Humans; Meta-Analysis as Topic; Piperazines; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sleep; Triazoles | 2002 |
Overview of psychiatric disorders and the role of newer antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Humans; Mental Disorders; Piperazines; Sleep Wake Disorders; Triazoles | 2002 |
Six-year perspectives on the safety and tolerability of nefazodone.
Topics: Age Factors; Antidepressive Agents, Second-Generation; Body Weight; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Obesity; Piperazines; Priapism; Seizures; Sexual Dysfunctions, Psychological; Suicide; Triazoles | 2002 |
Cost savings with nefazodone in treating depression.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cost Savings; Depressive Disorder; Drug Costs; Drug Therapy, Combination; Health Care Costs; Humans; Hypnotics and Sedatives; Piperazines; Sleep Wake Disorders; Triazoles | 2002 |
46 trial(s) available for triazoles and Depressive Disorder
| Article | Year |
|---|---|
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
Topics: Adult; Affect; Algorithms; Antidepressive Agents, Second-Generation; Delta Rhythm; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Monitoring, Ambulatory; Paroxetine; Piperazines; Signal Processing, Computer-Assisted; Sleep; Sleep, REM; Treatment Outcome; Triazoles | 2009 |
The relation between changes in patients' interpersonal impact messages and outcome in treatment for chronic depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Interpersonal Relations; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles | 2012 |
Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Triazoles | 2002 |
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
Topics: Adult; Antidepressive Agents, Second-Generation; Attitude to Health; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Personal Satisfaction; Piperazines; Psychiatric Status Rating Scales; Sex Factors; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles | 2002 |
Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Retrospective Studies; Treatment Outcome; Triazoles | 2002 |
Open-label nefazodone in patients with a major depressive episode and alcohol dependence.
Topics: Adult; Affect; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Memory; Middle Aged; Piperazines; Treatment Outcome; Triazoles | 2003 |
A comparison of antidepressant response in younger and older women.
Topics: Adult; Aged; Aging; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Sertraline; Sex Characteristics; Triazoles | 2003 |
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Self-Assessment; Treatment Outcome; Triazoles | 2005 |
Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Cocaine-Related Disorders; Depressive Disorder; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Piperazines; Triazoles | 2005 |
A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles | 1995 |
Nefazodone: aspects of efficacy.
Topics: Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Imipramine; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Survival Analysis; Treatment Outcome; Triazoles | 1995 |
Long-term treatment of depression with nefazodone.
Topics: Antidepressive Agents; Chronic Disease; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Piperazines; Triazoles | 1994 |
Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Triazoles | 1994 |
Nefazodone and imipramine in major depression: a placebo-controlled trial.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Triazoles | 1994 |
A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Patient Dropouts; Piperazines; Placebos; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Triazoles | 1994 |
The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Community Mental Health Services; Comorbidity; Depressive Disorder; Drug Administration Schedule; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Retrospective Studies; Treatment Outcome; Triazoles | 1996 |
Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles | 1996 |
Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles | 1996 |
A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles | 1996 |
Therapeutic dose range of nefazodone in the treatment of major depression.
Topics: Age Factors; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Piperazines; Treatment Outcome; Triazoles | 1996 |
An open-label trial of nefazodone in high comorbidity panic disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Panic Disorder; Piperazines; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Triazoles | 1996 |
Economic analysis of treating depression with nefazodone v. imipramine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; England; Humans; Imipramine; Models, Economic; Piperazines; Recurrence; Treatment Outcome; Triazoles; Wales | 1996 |
Curvaceous model of recovery from depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Humans; Models, Statistical; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1997 |
A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Outpatients; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sleep, REM; Triazoles | 1997 |
A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Topics: Adult; Affect; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Wake Disorders; Treatment Outcome; Triazoles | 1997 |
Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Sleep; Sleep Initiation and Maintenance Disorders; Triazoles | 1998 |
A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
Topics: Adult; Age of Onset; Analysis of Variance; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Headache; Hospitalization; Humans; Linear Models; Male; Nausea; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Triazoles | 1998 |
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Circadian Rhythm; Comorbidity; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Triazoles; Wakefulness | 1998 |
Open trial of nefazodone for combat-related posttraumatic stress disorder.
Topics: Adult; Ambulatory Care; Anger; Antidepressive Agents, Second-Generation; Combat Disorders; Depressive Disorder; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles | 1998 |
Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Female; HIV Seropositivity; Humans; Male; Patient Dropouts; Piperazines; Protease Inhibitors; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triazoles | 1999 |
Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Piperazines; Recurrence; Triazoles | 1999 |
Adjunctive nefazodone in neuroleptic-treated schizophrenic patients with predominantly negative symptoms: an open prospective pilot study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Serotonin Antagonists; Triazoles | 1999 |
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Piperazines; Treatment Outcome; Triazoles | 2000 |
Nefazodone treatment of adolescent depression: an open-label study of response and biochemistry.
Topics: Adolescent; Adolescent Behavior; Adolescent Psychiatry; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Piperazines; Serotonin; Treatment Outcome; Triazoles | 2000 |
Nefazodone pharmacokinetics in depressed children and adolescents.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Area Under Curve; Child; Cytochrome P-450 CYP2D6; Depressive Disorder; Female; Half-Life; Humans; Male; Piperazines; Treatment Outcome; Triazoles | 2000 |
Does nefazadone alone, the cognitive behavioral-analysis system of psychotherapy, or the combination of both work best for patients with chronic depression?
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Middle Aged; Piperazines; Triazoles | 2000 |
Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Female; Humans; Incidence; Male; Mental Disorders; Middle Aged; Panic Disorder; Piperazines; Prospective Studies; Remission, Spontaneous; Severity of Illness Index; Sex Factors; Sexual Behavior; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Treatment Outcome; Triazoles | 2001 |
Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Recurrence; Sertraline; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles | 2001 |
Which depressed patients respond to nefazodone and when?
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Patient Selection; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Triazoles | 2001 |
The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antidepressive Agents; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pindolol; Piperazines; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Triazoles; Tryptophan | 2001 |
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles | 2002 |
Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep, REM; Triazoles | 2002 |
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Female; Humans; Linear Models; Male; Outcome Assessment, Health Care; Personality Inventory; Piperazines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles | 2002 |
Symptom comorbidity in anxiety and depressive disorders.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Panic; Personality Assessment; Piperazines; Psychometrics; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles | 1990 |
Placebo-controlled dose-ranging trial designs in phase II development of nefazodone.
Topics: Depressive Disorder; Double-Blind Method; Humans; Piperazines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists; Triazoles | 1990 |
A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Piperazines; Randomized Controlled Trials as Topic; Triazoles | 1989 |
69 other study(ies) available for triazoles and Depressive Disorder
| Article | Year |
|---|---|
Can anti-inflammatory strategies light up the dim depression pipeline?
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Depression; Depressive Disorder; Drug Discovery; Humans; Inflammation; Pyridines; Triazoles | 2020 |
Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study.
Topics: Adult; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Depressive Disorder; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Letrozole; Middle Aged; Nitriles; Population Surveillance; Proportional Hazards Models; Retrospective Studies; Risk; Taiwan; Tamoxifen; Trastuzumab; Triazoles | 2015 |
Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement
Topics: Adenosine A2 Receptor Antagonists; Animals; CHO Cells; Cricetinae; Cricetulus; Depressive Disorder; Disease Models, Animal; Humans; Male; Mice; Movement Disorders; Neuroprotective Agents; Pyrimidines; Rats; Receptor, Adenosine A2A; Triazoles | 2009 |
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Genetic Association Studies; Humans; Male; Middle Aged; Paroxetine; Piperazines; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1B; Severity of Illness Index; Suicidal Ideation; Tacrolimus Binding Proteins; Triazoles; Venlafaxine Hydrochloride; Young Adult | 2011 |
Rhabdomyolysis with simvastatin and nefazodone.
Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles | 2002 |
[Acute liver failure in nefazodone therapy? A case report].
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Fatal Outcome; Humans; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Piperazines; Recurrence; Triazoles | 2002 |
Nefazodone poisoning: toxicokinetics and toxicodynamics using continuous data collection.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antidotes; Biotransformation; Blood Pressure; Charcoal; Depressive Disorder; Drug Overdose; Electrocardiography; Female; Fluid Therapy; Half-Life; Humans; Long QT Syndrome; Piperazines; Triazoles | 2003 |
Studies on the mechanism of catalase depression by toxohormone, with the aid of allylisopropylacetamide, allylisopropylacetylcarbamide, and 3-amino-1,2,4-triazole.
Topics: Allylisopropylacetamide; Amides; Amitrole; Azoles; Catalase; Depression; Depressive Disorder; Endotoxins; Hypnotics and Sedatives; Neoplasms; Triazoles; Urea | 1962 |
Rhabdomyolysis associated with simvastatin-nefazodone therapy.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles | 2003 |
The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain Chemistry; Depressive Disorder; Desipramine; Dopamine; Extracellular Space; Microdialysis; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Swimming; Triazoles | 2004 |
Dyskinetopsia during light adaptation associated with nefazodone treatment.
Topics: Adaptation, Ocular; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Motion Perception; Piperazines; Triazoles; Vision Disorders | 2003 |
Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors.
Topics: Adenosine; Animals; Antidepressive Agents; Caffeine; Depressive Disorder; Disease Models, Animal; Female; Male; Mice; Motor Activity; Receptor, Adenosine A1; Receptor, Adenosine A2A; Stress, Psychological; Triazines; Triazoles; Xanthines | 2004 |
Nefazodone-induced liver failure.
Topics: Depressive Disorder; Humans; Liver Failure, Acute; Male; Middle Aged; Piperazines; Triazoles | 2004 |
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
Topics: Adrenergic beta-Antagonists; Adult; Alleles; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzimidazoles; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Pindolol; Piperazines; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Triazoles | 2004 |
Medical management of depression.
Topics: Chemical and Drug Induced Liver Injury; Depressive Disorder; Duloxetine Hydrochloride; Humans; Liver Function Tests; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiophenes; Triazoles | 2006 |
An open-label study of nefazodone in the treatment of depression with and without comorbid obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents; Arousal; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Triazoles | 1994 |
Nefazodone for depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Humans; Piperazines; Triazoles | 1995 |
The effects of nefazodone on sleep architecture in depression.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Electroencephalography; Female; Humans; Male; Middle Aged; Piperazines; Sleep; Triazoles | 1994 |
The tridimensional personality questionnaire as a predictor of response to nefazodone treatment of depression.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Personality Development; Personality Inventory; Piperazines; Prognosis; Psychometrics; Regression Analysis; Triazoles | 1995 |
Nefazodone: a novel antidepressant.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Piperazines; Treatment Outcome; Triazoles | 1995 |
Development of obsessive symptoms during nefazodone treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Obsessive-Compulsive Disorder; Piperazines; Triazoles | 1996 |
Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition.
Topics: Alprazolam; Antidepressive Agents, Second-Generation; Anxiety; Cytochrome P-450 Enzyme Inhibitors; Depression; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Treatment Outcome; Triazoles | 1996 |
Antidepressant-induced mania.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Triazoles | 1995 |
Paresthesia as a side effect of the new antidepressant, nefazodone.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Paresthesia; Piperazines; Triazoles | 1995 |
New perspectives in the management of depression. Symposium highlights from ECNP, Venice, September 1995.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Imipramine; Piperazines; Triazoles | 1996 |
Visual "trails" with nefazodone treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Optical Illusions; Perceptual Disorders; Piperazines; Triazoles; Visual Perception | 1996 |
Three new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1996 |
Nefazodone and akathisia.
Topics: Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Clonazepam; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Propranolol; Triazoles | 1996 |
Familial akathisia and depression treated with nefazodone.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Piperazines; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors; Triazoles | 1996 |
Nefazodone-induced spontaneous ejaculation.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Ejaculation; Humans; Male; Middle Aged; Piperazines; Sexual Dysfunctions, Psychological; Triazoles | 1996 |
Priapism: trazodone versus nefazodone.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Priapism; Trazodone; Triazoles | 1996 |
Probable nefazodone-induced mania in a patient with unreported bipolar disorder.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Patient Care Team; Piperazines; Premenstrual Syndrome; Triazoles | 1996 |
Hair loss associated with nefazodone.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Hypotrichosis; Piperazines; Triazoles | 1997 |
Nefazodone-induced hypoglycemia in a diabetic patient with major depression.
Topics: Antidepressive Agents, Second-Generation; Blood Glucose; Depressive Disorder; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemia; Middle Aged; Piperazines; Triazoles | 1997 |
Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Depressive Disorder; Drug Costs; Fluoxetine; Health Care Costs; Health Policy; Health Services; Humans; Imipramine; Managed Care Programs; Patient Compliance; Piperazines; Probability; Quality-Adjusted Life Years; Treatment Failure; Treatment Outcome; Triazoles | 1997 |
Sertraline-induced anorgasmia treated with intermittent nefazodone.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Orgasm; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles | 1997 |
Nefazodone-induced mania.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles | 1997 |
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 1997 |
Nefazodone and visual side effects.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles; Vision Disorders | 1997 |
Nefazodone. Psychomotor and cognitive effects.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cognition; Depressive Disorder; Humans; Middle Aged; Piperazines; Psychomotor Performance; Triazoles | 1997 |
Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Inventory; Pindolol; Piperazines; Treatment Outcome; Triazoles | 1997 |
Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study.
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Regression Analysis; Temperament; Triazoles | 1997 |
[Nefazodone: a new antidepressive agent. Advantages of a dual working principle].
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Piperazines; Sleep; Sleep Initiation and Maintenance Disorders; Triazoles | 1997 |
Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Platelets; Carrier Proteins; Depressive Disorder; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Triazoles | 1998 |
Nefazodone withdrawal symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Phobic Disorders; Piperazines; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Triazoles | 1998 |
Treatment of depressed methadone maintenance patients with nefazodone. A case series.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Piperazines; Treatment Outcome; Triazoles | 1998 |
Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Paroxetine; Piperazines; Tacrolimus; Triazoles | 1998 |
Nefazodone for mood disorder associated with epilepsy.
Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Depressive Disorder; Epilepsy; Humans; Male; Piperazines; Treatment Outcome; Triazoles | 1998 |
Modelling the cost effectiveness of antidepressant treatment in primary care.
Topics: Antidepressive Agents; Decision Support Techniques; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Markov Chains; Models, Economic; Piperazines; Primary Health Care; Quality-Adjusted Life Years; Sensitivity and Specificity; Triazoles | 1995 |
Nefazodone-induced clitoral priapism.
Topics: Antidepressive Agents, Second-Generation; Clitoris; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles; Vaginal Diseases | 1999 |
Discontinuation symptoms with nefazodone.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles | 1999 |
Nafazodone-induced palinopsia.
Topics: Afterimage; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Triazoles | 2000 |
Treatment of chronic depression.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Triazoles | 2000 |
Nefazodone-associated subjective complaints of burning sensations.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Middle Aged; Paresthesia; Piperazines; Triazoles | 2000 |
Antidepressants and the serotonin syndrome in general practice.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Family Practice; Female; Humans; Male; Medical Records; Middle Aged; Piperazines; Serotonin Syndrome; Triazoles | 1999 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
Nefazodone, psychotherapy, and their combination for chronic depression.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Piperazines; Placebos; Psychotherapy; Research Design; Triazoles | 2000 |
Nefazodone, psychotherapy, and their combination for chronic depression.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Piperazines; Psychotherapy; Research Design; Triazoles | 2000 |
Nefazodone, psychotherapy, and their combination for chronic depression.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Humans; Outcome Assessment, Health Care; Piperazines; Placebos; Psychotherapy; Triazoles | 2000 |
Nefazodone, psychotherapy, and their combination for chronic depression.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Psychotherapy; Severity of Illness Index; Triazoles | 2000 |
Psychotherapy vindicated?
Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Triazoles | 2000 |
[The antidepressant nefazodone. Healthy sleep fosters compliance].
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Patient Compliance; Piperazines; Sleep Stages; Treatment Outcome; Triazoles | 2001 |
Remission of SSRI-induced akathisia after switch to nefazodone.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles | 2001 |
Nefazodone may inhibit the metabolism of carbamazepine: three case reports.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles | 2001 |
Long-term treatment of recurrent and chronic depression.
Topics: Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost of Illness; Depressive Disorder; Disability Evaluation; Drug Administration Schedule; Fluoxetine; Humans; Piperazines; Placebos; Recurrence; Treatment Outcome; Triazoles | 2001 |
Possible interaction of zopiclone and nefazodone.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Azabicyclo Compounds; Depressive Disorder; Diabetes Mellitus, Type 2; Drug Interactions; Female; Humans; Hypnotics and Sedatives; Piperazines; Triazoles | 2001 |
Hepatotoxicity associated with the new antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Drug Monitoring; Female; Humans; Incidence; Liver Diseases; Piperazines; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Triazoles | 2002 |
Antidepressant dosing and switching guidelines: focus on nefazodone.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Humans; Piperazines; Practice Guidelines as Topic; Secondary Prevention; Triazoles | 2002 |
Novel serotonergic mechanisms and clinical experience with nefazodone.
Topics: Animals; Antidepressive Agents; Depressive Disorder; Humans; Piperazines; Serotonin; Triazoles | 1992 |